Alnylam Pharmaceuticals Inc “RNAi Roundtable” Webcast Series: CNS & Extrahepatic RNAi Pipeline Programs Transcript
Hi, everyone. Welcome to this RNAi Roundtable. Thank you for joining us. Today, we're going to be discussing the progress that we're making across our central nervous system and broader extrahepatic delivery efforts. I'm Josh Brodsky, Senior Director of Investor Relations and Corporate Communications at Alnylam. And I'm joined today by my colleagues, Vasant Jadhav, Senior Vice President of Research; Kirk Brown, Senior Director of the CNS program; and Bret Bostwick, Director of Clinical Research.
Today's RNAi Roundtable is part of a series of roundtable webinars that we have been hosting over the past few months to review progress across our various programs. The event today is expected to run approximately 60 to 75 minutes. Vasant will moderate a Q&A session at the conclusion of the presentations.
(Operator Instructions)
As a reminder, we will be making forward-looking statements during this webinar, and we encourage you to read our most recent SEC filings for a more complete
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
